Global Rivaroxaban Market by Manufacturers, Regions, Type and Application, Forecast to 2023
Rivaroxaban is an oral
anticoagulant invented and manufactured by Bayer; in a number of countries it
is marketed as Xarelto. In the United States, it is marketed by Janssen
Pharmaceutica. It is the first available orally active direct factor Xa
inhibitor. Rivaroxaban is well absorbed from the gut and maximum inhibition of
factor Xa occurs four hours after a dose. The effects last approximately 8–12
hours, but factor Xa activity does not return to normal within 24 hours so
once-daily dosing is possible.
Scope of the Report:
This report focuses on the Rivaroxaban in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The global average price of Rivaroxaban is in the decreasing trend, from 5.62 USD/Unit in 2011 to 5.34 USD/Unit in 2015. With the situation of global economy, prices will be in slowly decreasing trend in the following five years.
Bayer is the only supplier of Rivaroxaban enjoying production market share100% in 2015 and it will still in this situation until 2023.
The worldwide market for Rivaroxaban is expected to grow at a CAGR of roughly 9.4% over the next five years, will reach 10100 million US$ in 2023, from 5860 million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Bayer
J&J
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
2.5 mg
10 mg
15 mg
20 mg
Market Segment by Applications, can be divided into
Acute Coronary Syndrome (ACS)
Venous Thromboembolism (VTE)
This report focuses on the Rivaroxaban in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The global average price of Rivaroxaban is in the decreasing trend, from 5.62 USD/Unit in 2011 to 5.34 USD/Unit in 2015. With the situation of global economy, prices will be in slowly decreasing trend in the following five years.
Bayer is the only supplier of Rivaroxaban enjoying production market share100% in 2015 and it will still in this situation until 2023.
The worldwide market for Rivaroxaban is expected to grow at a CAGR of roughly 9.4% over the next five years, will reach 10100 million US$ in 2023, from 5860 million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Bayer
J&J
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
2.5 mg
10 mg
15 mg
20 mg
Market Segment by Applications, can be divided into
Acute Coronary Syndrome (ACS)
Venous Thromboembolism (VTE)
Full report with Table of Content:
https://marketreportscenter.com/reports/595390/global-rivaroxaban-market-by-manufacturers-regions-type-and-application-forecast-to-2023
There are 15 Chapters to
deeply display the global Rivaroxaban market.
Chapter 1, to describe Rivaroxaban Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Rivaroxaban, with sales, revenue, and price of Rivaroxaban, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Rivaroxaban, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Rivaroxaban market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Rivaroxaban sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
Chapter 1, to describe Rivaroxaban Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Rivaroxaban, with sales, revenue, and price of Rivaroxaban, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Rivaroxaban, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Rivaroxaban market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Rivaroxaban sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
…
About
Market Reports Center;
Market Reports Center is an e-commerce platform
obliging the needs of knowledge workers, experts, professionals who are subject
to market research information for their work, or to make strategic business
decisions. We are dedicated to create a comprehensive offering of market
research which is accurate, credible and affordable.
Connect
for more details:
Sam
Collins
Market
Reports Center
1-646-883-3044
(US)
Comments
Post a Comment